Notice: This company has been marked as potentially delisted and may not be actively trading. Selecta Biosciences (SELB) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Leigh Francis insists Bo Selecta! reboot will never happenOctober 20, 2024 | msn.comLeigh Francis in Leeds: Keith Lemon and Bo Selecta! star announces evening of laughter at Leeds Grand TheatreSeptember 23, 2024 | msn.comLeigh Francis interview: Leeds comedian of Keith Lemon and Bo' Selecta! fame on his fear of being cancelledSeptember 20, 2024 | msn.comCraig David says Leigh Francis' Bo Selecta! skit 'sent him down a dark road'May 6, 2024 | msn.comSelb, Germany - Weather Forecasts | Maps | News - Yahoo WeatherJanuary 23, 2024 | yahoo.comCartesian Therapeutics Inc (RNAC)December 15, 2023 | investing.comFurther weakness as Selecta Biosciences (NASDAQ:SELB) drops 17% this week, taking five-year losses to 85%November 14, 2023 | finance.yahoo.comPared-down Selecta merges with Maryland biotechNovember 13, 2023 | bizjournals.comSelecta Biosciences Merges With Cartesian To Focus On Autoimmune Cell TherapyNovember 13, 2023 | msn.comSelecta Biosciences Merges With Cartesian Therapeutics In All-stock DealNovember 13, 2023 | markets.businessinsider.comTrading was temporarily halted for "SELB" at 08:11 AM with a stated reason of "News pending."November 13, 2023 | marketbeat.comSHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Selecta Biosciences, Inc. (NASDAQ: SELB) and Encourages Investors to Contact the FirmNovember 11, 2023 | benzinga.comSelecta Biosciences Inc SELBNovember 10, 2023 | morningstar.comSelecta Biosciences in Deal to Transfer Manufacturing, Development Rights of Sel-212 TreatmentOctober 31, 2023 | marketwatch.comSelecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner SobiOctober 31, 2023 | finance.yahoo.comSelecta Biosciences files for $200M mixed shelfOctober 25, 2023 | msn.comMizuho Maintains Selecta Biosciences (SELB) Buy RecommendationAugust 19, 2023 | msn.comSVB Leerink Downgrades Selecta Biosciences (SELB)August 19, 2023 | msn.comAnalyst Ratings for Selecta BiosciencesAugust 18, 2023 | markets.businessinsider.comNeedham Maintains Selecta Biosciences (SELB) Buy RecommendationAugust 18, 2023 | msn.comSelecta Biosciences (SELB) Gets a Buy from H.C. WainwrightAugust 18, 2023 | markets.businessinsider.comSelecta Biosciences (NASDAQ:SELB) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPSSelecta Biosciences (NASDAQ:SELB - Get Free Report) announced its earnings results on Thursday. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.05. Selecta Biosciences had a negative net margin of 18.21% and a negative return on equity of 17.67%. The company had revenue of $5.25 million for the quarter, compared to analysts' expectations of $9.90 million.August 18, 2023 | marketbeat.comSelecta Biosciences' (SELB) "Market Perform" Rating Reaffirmed at SVB LeerinkSVB Leerink reaffirmed a "market perform" rating and issued a $1.00 price target on shares of Selecta Biosciences in a report on Friday.August 18, 2023 | marketbeat.comMizuho Securities Reaffirms Their Buy Rating on Selecta Biosciences (SELB)August 17, 2023 | markets.businessinsider.comQ2 2023 Selecta Biosciences Inc Earnings CallAugust 17, 2023 | finance.yahoo.comSelecta Biosciences Narrows R&D Focus On Gout CandidateAugust 17, 2023 | msn.comSelecta Biosciences, Inc. (SELB) Reports Q2 Loss, Misses Revenue EstimatesAugust 17, 2023 | finance.yahoo.comSelecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 EconomicsAugust 17, 2023 | finance.yahoo.comSelecta Biosciences, Inc.'s (NASDAQ:SELB) largest shareholders are individual investors with 35% ownership, institutions own 26%July 14, 2023 | finance.yahoo.comSelecta Biosciences (NASDAQ:SELB) Rating Lowered to Hold at StockNews.comStockNews.com cut Selecta Biosciences from a "buy" rating to a "hold" rating in a report on Friday.June 9, 2023 | marketbeat.comSelecta Biosciences, Inc. (NASDAQ:SELB) Shares Sold by GSA Capital Partners LLPGSA Capital Partners LLP cut its holdings in shares of Selecta Biosciences, Inc. (NASDAQ:SELB - Get Rating) by 48.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 372,087 shares of theJune 8, 2023 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Sells 119,611 Shares of Selecta Biosciences, Inc. (NASDAQ:SELB)Connor Clark & Lunn Investment Management Ltd. decreased its holdings in shares of Selecta Biosciences, Inc. (NASDAQ:SELB - Get Rating) by 81.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 27,239 shJune 6, 2023 | marketbeat.comSelecta Biosciences (NASDAQ:SELB) shareholders are up 22% this past week, but still in the red over the last five yearsJune 3, 2023 | finance.yahoo.comSelecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of RheumatologyMay 31, 2023 | finance.yahoo.comSelecta Biosciences, Inc. (NASDAQ:SELB) Receives Consensus Rating of "Moderate Buy" from BrokeragesSelecta Biosciences, Inc. (NASDAQ:SELB - Get Rating) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendatMay 12, 2023 | marketbeat.comNewsflash: Selecta Biosciences, Inc. (NASDAQ:SELB) Analysts Have Been Trimming Their Revenue ForecastsMay 9, 2023 | finance.yahoo.comHC Wainwright & Co. Reiterates Selecta Biosciences (SELB) Buy RecommendationMay 8, 2023 | msn.comStockNews.com Downgrades Selecta Biosciences (NASDAQ:SELB) to HoldStockNews.com cut Selecta Biosciences from a "buy" rating to a "hold" rating in a research note on Friday.May 5, 2023 | marketbeat.comSelecta cuts in-house gene therapy programs, lays off 15May 5, 2023 | bizjournals.comMizuho Securities Sticks to Their Buy Rating for Selecta Biosciences (SELB)May 4, 2023 | markets.businessinsider.comSelecta Biosciences, Inc. (SELB) Reports Q1 Loss, Misses Revenue EstimatesMay 4, 2023 | finance.yahoo.comSelecta Biosciences, Inc.: Selecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 4, 2023 | finanznachrichten.deSelecta Biosciences Reports First Quarter 2023 Financial Results and Provides Business UpdateMay 4, 2023 | finance.yahoo.comSelecta Biosciences to Host Conference Call and Webcast to Discuss First Quarter 2023 Financial Results and Provide Business UpdateApril 28, 2023 | finance.yahoo.comInvestors Holding Back On Selecta Biosciences, Inc. (NASDAQ:SELB)April 18, 2023 | finance.yahoo.comNeedham Reiterates Selecta Biosciences (SELB) Buy RecommendationApril 13, 2023 | msn.comWhat 6 Analyst Ratings Have To Say About Selecta BiosciencesApril 13, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR), Selecta Biosciences (SELB) and Denali Therapeutics (DNLI)April 13, 2023 | markets.businessinsider.comIs Selecta Biosciences, Inc.'s (NASDAQ:SELB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?March 27, 2023 | finance.yahoo.comThe Latest Analyst Ratings for Selecta BiosciencesMarch 22, 2023 | markets.businessinsider.com Get Selecta Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon Musk’s next tweet could help pay for your retirement (Ad)Elon Musk says the government is going bankrupt. Seniors are getting crushed by inflation. But there is a way you could claim a chunk of over $1 trillion in spending, courtesy of Elon Musk. SELB Media Mentions By Week SELB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SELB News Sentiment▼0.000.64▲Average Medical News Sentiment SELB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SELB Articles This Week▼00▲SELB Articles Average Week Get Selecta Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SELB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LianBio News Today PHAXIAM Therapeutics News Today Alpha Tau Medical News Today Apollomics News Today BriaCell Therapeutics News Today enGene News Today Fortress Biotech News Today GeoVax Labs News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SELB) was last updated on 1/2/2025 by MarketBeat.com Staff From Our Partners3 CENT Crypto to Explode December 16th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredApple feeling the heat from NvidiaNvidia has moved on to the next frontier of AI it intends to dominate. And we believe the three companies p...Weiss Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Selecta Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Selecta Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
